Status: Not yet recruiting
The Prospective, Multicenter, Randomized Controlled Trial of the VentriCure Interventional Left Ventricular Assist System
This study aims to evaluate the safety and effectiveness of the VentriCure interventional left ventricular assist system for short-term ventricular support during high-risk percutaneous coronary intervention (HRPCI) in non-emergent, hemodynamically stable coronary artery disease patients via a prospective, multi-center, randomized controlled clinical trial.
Participants needed: 220
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Life Shield Medical Technology Co., LTDUpdated: Jun 30, 2026
Eligibility criteria
Patient age ≥18 years old; [+1]
Cardiac arrest within 24 hours; [+13]